Why the study?
Does fetal cardiac intervention improve biventricular circulation, live birth, and postnatal mortality in fetuses with congenital heart disease compared to expectant management?
Population
775 fetuses with congenital heart disease from 11 comparative observational studies.
Comparison
Fetal cardiac intervention, including fetal… vs Expectant management.
Design
Meta-analysis
Follow-up
postnatal
Key result
Fetal cardiac intervention was associated with significantly lower odds of postnatal death among live-born infants compared with expectant management (OR 0.457), without a significant difference in live birth rates.
Authors
Loading...
Supports FCI to lower postnatal mortality in fetal CHD; extends Level 1 meta-analytic evidence for select lesions.
Meta-Analysis (n=775)
Does fetal cardiac intervention improve biventricular circulation, live birth, and postnatal mortality in fetuses with congenital heart disease compared to expectant management?
Odds Ratio: 0.457 (95% CI 0.28–0.746)
Absolute Event Rate: 19.6% vs 32.8%
p-value: p=0.002
Fetal cardiac intervention, particularly fetal aortic valvuloplasty, is associated with significantly lower postnatal mortality among live-born infants compared to expectant management, though evidence for other interventions remains sparse.
Ning et al. (2026) conducted a meta-analysis in Congenital heart disease (n=775). Fetal cardiac intervention vs. Expectant management was evaluated on Postnatal death among live-born infants (OR 0.457, 95% CI 0.280-0.746, p=0.002). Fetal cardiac intervention was associated with significantly lower odds of postnatal death among live-born infants compared with expectant management (OR 0.457), without a significant difference in live birth rates.